Ling Yi Selected Research

Ling Yi Research Topics

Disease

8	Neoplasms (Cancer) 11/2022 - 01/2014
8	Menkes Kinky Hair Syndrome (Menkes Disease) 09/2020 - 12/2011
5	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 04/2019
4	Infections 01/2021 - 10/2004
3	Pain (Aches) 01/2017 - 03/2009
2	Circulating Neoplastic Cells 07/2021 - 04/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2018 - 12/2011
2	Dysmenorrhea (Menstrual Pain) 01/2017 - 01/2014
2	Tuberculosis (Tuberculoses) 06/2015 - 12/2011
2	Occipital horn syndrome 05/2015 - 05/2014
1	Adenocarcinoma of Lung 11/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022
1	Lewis Lung Carcinoma 01/2022
1	Dehydration (Water Stress) 12/2021
1	Shock 12/2021
1	Dysbiosis 09/2021
1	Fatty Liver 09/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Congenital Heart Defects (Congenital Heart Defect) 01/2021
1	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2021
1	Stroke (Strokes) 10/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2019
1	Breast Neoplasms (Breast Cancer) 07/2019
1	Stillbirth 02/2016
1	Lung Diseases (Lung Disease) 06/2015
1	Pleural Effusion (Pleural Effusions) 06/2015
1	Multiple Myeloma 08/2014
1	Motor Neuron Disease (Primary Lateral Sclerosis) 05/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Heart Neoplasms 01/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2012
1	Muscular Diseases (Myopathy) 04/2012
1	Dementia (Dementias) 04/2012
1	Sepsis (Septicemia) 01/2012
1	Inflammation (Inflammations) 03/2009

Drug/Important Bio-Agent (IBA)

4	CopperIBA 09/2020 - 12/2011
4	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2014
3	CytokinesIBA 07/2021 - 01/2012
3	Copper Transport ProteinsIBA 09/2018 - 04/2014
2	LigandsIBA 11/2022 - 07/2021
2	Messenger RNA (mRNA)IBA 12/2019 - 01/2015
2	Monoclonal AntibodiesIBA 06/2015 - 01/2014
2	P-type ATPasesIBA 05/2015 - 12/2011
1	Immune Checkpoint ProteinsIBA 11/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Polyethylene Glycol 6000IBA 12/2021
1	Abscisic AcidIBA 12/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2021
1	Volatile Fatty AcidsIBA 09/2021
1	PrebioticsIBA 09/2021
1	ButyrophilinsIBA 03/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Complement System Proteins (Complement)IBA 09/2020
1	4-1BB Ligand (4 1BB Ligand)IBA 12/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2019
1	chiglitazarIBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 07/2019
1	pyrotinibIBA 07/2019
1	Programmed Cell Death 1 ReceptorIBA 06/2019
1	AntigensIBA 06/2019
1	ErbB Receptors (EGF Receptor)IBA 04/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Dinoprostone (PGE2)FDA Link 01/2017
1	Chimeric Antigen ReceptorsIBA 08/2014
1	NucleotidesIBA 04/2014
1	PhytochemicalsIBA 01/2014
1	Plant ExtractsIBA 01/2014
1	UbiquitinIBA 04/2012
1	ChemokinesIBA 01/2012
1	EnzymesIBA 12/2011
1	Indicators and Reagents (Reagents)IBA 12/2011
1	ImmunosorbentsIBA 12/2011
1	Gold Colloid (Colloidal Gold)IBA 12/2011
1	AntibodiesIBA 12/2011
1	integrin alpha4beta7IBA 12/2009
1	Iridoid GlucosidesIBA 03/2009
1	harpagosideIBA 03/2009
1	LuteolinIBA 10/2004
1	beta-d-glucoseIBA 10/2004

Therapy/Procedure

2	Therapeutics 11/2022 - 06/2019
2	Moxibustion 01/2017 - 01/2014
1	Immunotherapy 01/2022
1	Immunomodulation 03/2021
1	Secondary Prevention 10/2020
1	Aftercare (After-Treatment) 01/2017
1	Prenatal Care (Care, Prenatal) 02/2016